February 26, 2018 / 3:23 AM / 7 months ago

BRIEF-Polus BioPharm to issue 26th series convertible bonds worth 20 bln won

Feb 26 (Reuters) - Polus BioPharm Inc :

* Says it will issue 26th series unregistered and unsecured private convertible bonds, to raise 20 billion won in proceeds for operations

* Maturity date is March 9, 2023, coupon rate is 4 percent and yield to maturity is 4 percent for the bonds

* Conversion price is 15,759 won/share and conversion ratio is 100 percent

Source text in Korean: goo.gl/vn7PQJ

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below